Testing an experimental vaccine during a public health emergency: Lessons from a Peruvian case
The COVID-19 health emergency created an environment where existing regulatory and ethical principles were circumvented under political pressure. Regulatory bodies and agencies should inform countries of the dangers of conducting clinical trials during a public health emergency and proper ethical and regulatory procedures should be followed.
Authors
- Theresa Jean Ochoa (ORCID: https://orcid.org/0000-0002-3227-3906)
- Kathryn M. Edwards (ORCID: https://orcid.org/0000-0003-3912-9832)
- Ruth Faden (ORCID: https://orcid.org/0009-0001-8601-8783)
- Claudio F. Lanata (ORCID: https://orcid.org/0000-0002-6994-7425)
- Hanna Nohynek (ORCID: https://orcid.org/0000-0001-8220-3669)
- Charles Weijer (ORCID: https://orcid.org/0000-0002-5510-1074)
- Shabir Ahmed Madhi (ORCID: https://orcid.org/0000-0002-7629-0636)
- Norman W. Baylor
- Eduardo Bancalari
Institutions
- Western University (CA)
- University of Piura (PE)
- University of the Witwatersrand (ZA)
- Universidad Peruana Cayetano Heredia (PE)
- Vanderbilt University (US)
- Finnish Institute for Health and Welfare (FI)
- Johns Hopkins Berman Institute of Bioethics (US)
- Link Consulting (PT)
- Instituto de Investigación Nutricional (PE)
Publication Details
- Journal
- Vaccine
- Published
- 2025-04-24
- DOI
- https://doi.org/10.1016/j.vaccine.2025.127176
- Citations
- 1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 1.40